ZA988446B - Production of vaccines using arthropod vectored viruses. - Google Patents

Production of vaccines using arthropod vectored viruses.

Info

Publication number
ZA988446B
ZA988446B ZA9808446A ZA988446A ZA988446B ZA 988446 B ZA988446 B ZA 988446B ZA 9808446 A ZA9808446 A ZA 9808446A ZA 988446 A ZA988446 A ZA 988446A ZA 988446 B ZA988446 B ZA 988446B
Authority
ZA
South Africa
Prior art keywords
membrane
membranes
viruses
vaccine
proteins
Prior art date
Application number
ZA9808446A
Other languages
English (en)
Inventor
Dennis T Brown
Racquel Hernandez
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of ZA988446B publication Critical patent/ZA988446B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9808446A 1997-09-18 1998-09-16 Production of vaccines using arthropod vectored viruses. ZA988446B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5966897P 1997-09-18 1997-09-18

Publications (1)

Publication Number Publication Date
ZA988446B true ZA988446B (en) 2000-03-22

Family

ID=22024455

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9808446A ZA988446B (en) 1997-09-18 1998-09-16 Production of vaccines using arthropod vectored viruses.

Country Status (16)

Country Link
US (1) US6306401B1 (xx)
EP (1) EP1037603B1 (xx)
JP (1) JP4318399B2 (xx)
KR (1) KR20010024148A (xx)
CN (1) CN1284859C (xx)
AT (1) ATE345813T1 (xx)
AU (1) AU737088B2 (xx)
CA (1) CA2302809C (xx)
DE (1) DE69836499T2 (xx)
HK (1) HK1033544A1 (xx)
IL (2) IL134978A0 (xx)
NZ (1) NZ503128A (xx)
RU (1) RU2218403C2 (xx)
TW (1) TW589381B (xx)
WO (1) WO1999013818A2 (xx)
ZA (1) ZA988446B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7335363B2 (en) 1997-09-18 2008-02-26 Research Development Foundation Membrane virus host range mutations and their uses as vaccine substrates
US7128915B2 (en) * 1997-09-18 2006-10-31 Research Development Foundation Membrane virus host range mutations and their uses as vaccine substrates
US6589533B1 (en) * 1997-09-18 2003-07-08 Research Development Foundation Genetically-engineered alphaviruses, flaviviruses, and bunyaviruses with modified envelope transmembrane glycoproteins and altered host-range phenotype
CA2337905A1 (en) * 1998-07-30 2000-03-02 Johns Hopkins University School Of Medicine Targeted alphavirus and alphaviral vectors
US20070020238A1 (en) * 2005-06-01 2007-01-25 David Baltimore Method of targeted gene delivery using viral vectors
CN100427918C (zh) * 2006-06-05 2008-10-22 中国科学院南海海洋研究所 一种海水鱼类卵子电镜扫描样品制备方法
EP2520168B1 (en) 2006-07-21 2014-03-19 California Institute of Technology Targeted gene delivery for dendritic cell vaccination
NZ597804A (en) 2009-07-24 2013-10-25 Immune Design Corp Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
WO2011119628A2 (en) * 2010-03-23 2011-09-29 The Regents Of The University Of California Compositions and methods for self-adjuvanting vaccines against microbes and tumors
BR112012024224A2 (pt) * 2010-03-24 2016-11-29 Arbovax Inc mutações da faixa de hospedeiro de flavivírus e seu uso.
US8889148B2 (en) 2010-07-01 2014-11-18 Research Development Foundation Flavivirus host-range mutations and uses thereof
US8323662B1 (en) 2012-03-30 2012-12-04 Immune Design Corp. Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein
US9713635B2 (en) 2012-03-30 2017-07-25 Immune Design Corp. Materials and methods for producing improved lentiviral vector particles
AU2013237900B2 (en) 2012-03-30 2017-07-27 Immune Design Corp. Lentiviral vector particles having improved transduction efficiency for cells expressing DC- SIGN
US8895028B2 (en) * 2012-07-20 2014-11-25 Arbovax, Inc. Methods and compositions for dengue virus 3 (DV3) infectious clone
WO2014052588A1 (en) 2012-09-27 2014-04-03 Research Development Foundation Attenuated chikungunya virus
AR107262A1 (es) 2016-01-27 2018-04-11 Lilly Co Eli Inactivación de patógenos por delipidación
CN109943592B (zh) * 2019-04-29 2020-11-17 华中农业大学 含猪伪狂犬病病毒gD蛋白基因的重组杆状病毒转移载体、重组杆状病毒及制备方法和应用

Also Published As

Publication number Publication date
DE69836499T2 (de) 2007-10-11
ATE345813T1 (de) 2006-12-15
KR20010024148A (ko) 2001-03-26
NZ503128A (en) 2001-08-31
CA2302809C (en) 2011-08-09
EP1037603A1 (en) 2000-09-27
TW589381B (en) 2004-06-01
EP1037603A4 (en) 2004-03-17
IL134978A (en) 2008-03-20
RU2218403C2 (ru) 2003-12-10
CN1284859C (zh) 2006-11-15
AU737088B2 (en) 2001-08-09
HK1033544A1 (en) 2001-09-07
IL134978A0 (en) 2001-05-20
WO1999013818A3 (en) 2003-12-04
JP2003525564A (ja) 2003-09-02
EP1037603B1 (en) 2006-11-22
JP4318399B2 (ja) 2009-08-19
US6306401B1 (en) 2001-10-23
DE69836499D1 (de) 2007-01-04
CA2302809A1 (en) 1999-03-25
CN1553961A (zh) 2004-12-08
WO1999013818A2 (en) 1999-03-25
AU9399698A (en) 1999-04-05

Similar Documents

Publication Publication Date Title
ZA988446B (en) Production of vaccines using arthropod vectored viruses.
Hernández et al. The hallmarks of cell-cell fusion
Pecheur et al. Peptides and membrane fusion: towards an understanding of the molecular mechanism of protein-induced fusion
Langosch et al. The role of transmembrane domains in membrane fusion
DE59608743D1 (de) Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte-fermentation
WO2003068947A8 (en) Assay electrodes having immobilized lipid/protein layers and methods of making and using the same
EP1555319A3 (en) Modified nucleic acid sequences and method to increasing mRNA levels and protein expression in cell systems
EP1746162A3 (en) Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
ATE278024T1 (de) Methode zur herstellung von rekombinanten zellen
DE69632827D1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
IS2163B (is) Vatnsfælanlega-umbreyttar prótín samsetningar og aðferðir
WO2000034474A3 (en) Growth factor homolog zvegf3
AU5668100A (en) Peptide conjugates for the stabilization of membrane proteins and interactions with biological membranes
BR9811675A (pt) Genes isolados para proteìna da membrana de célula dentrìtica
WO2001042283A3 (en) Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
JP2011505850A5 (xx)
ATE299944T1 (de) System zur herstellung von proteinen
Sobel Myosin rings and spreading in mouse blastomeres.
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
Hand et al. Basic mechanisms of cellular secretion
Langiade-Demoyen et al. Primary cytotoxic T lymphocyte induction using peptide-stripped autologous cells
ATE339448T1 (de) Verfahren zur trennung von glykosylierten und nicht-glykosylierten proteinen
Kvist et al. Early events in the assembly of MHC class I antigens
WO2000002909A3 (en) Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins
RU94046397A (ru) Линия клеток млекопитающих, композиция, способы получения и очистки полипептида